Evolus

EOLS54

$16.55arrow_drop_up0.66%$0.11

EOLS54

$16.55

arrow_drop_up0.66%$0.11

Performance History

Key Stats
Open	$16.46
Prev. Close	$16.44
EPS	-0.90
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	16.38	17.08
52 Week Range	7.44	17.70

Ratios







EPS	-0.90

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Evolus (EOLS)

Evolus Inc (EOLS) is a pharmaceutical company specializing in the development and commercialization of medical aesthetic products. The company's stock price history shows fluctuations over the years, reflecting investor sentiment and market conditions. It is important for potential investors to analyze the stock's performance before making any investment decisions. By reviewing the stock's price history, investors can gain insights into its volatility and potential for growth.

For current information on Evolus Inc, it is recommended to check the latest stock quote. The stock quote provides real-time data on the stock's price, volume, and other key metrics. This information can help investors make informed decisions regarding buying or selling shares of Evolus Inc.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. David Moatazedi
Headquarters: Newport Beach
Employees: 215
Exchange: NASDAQ

Keep an eye on Evolus

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Evolus 's (EOLS) price per share?

The current price per share for Evolus (EOLS) is $16.55. The stock has seen a price change of $0.11 recently, indicating a 0.67% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Evolus (EOLS)?

For Evolus (EOLS), the 52-week high is $17.7, which is 6.95% from the current price. The 52-week low is $7.44, the current price is 122.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Evolus (EOLS) a growth stock?

Evolus (EOLS) has shown an average price growth of 0.41% over the past three years. It has received a score of 73 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Evolus as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Evolus (EOLS) stock price performance year to date (YTD)?

As of the latest data, Evolus (EOLS) has a year-to-date price change of 65.67%. Over the past month, the stock has experienced a price change of 5.68%. Over the last three months, the change has been 56.87%. Over the past six months, the figure is 20.01%. Looking at a longer horizon, the five-year price change stands at -7.33%.

help

Is Evolus (EOLS) a profitable company?

Evolus (EOLS) has a net income of -$61.68M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 67% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -9.11% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $202.08M, with a revenue growth rate of 35.98%, providing insight into the company's sales performance and growth. The gross profit is $135.39M. Operating income is noted at -$36.11M. Furthermore, the EBITDA is -$24.64M.

help

What is the market capitalization of Evolus (EOLS)?

Evolus (EOLS) has a market capitalization of $1.04B. The average daily trading volume is 805.91K, indicating the stock's liquidity and investor engagement.